David G Spiller (Dave Spiller, David Spiller)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Interstitial Lung Disease

Helicobacter Pylori

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Disease models & mechanisms

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Pickard, Richa Garva, Antony D Adamson, Ben C Calverley, Anna Hoyle, Christina E Hayward, David G Spiller, Yinhui Lu, Nigel W Hodson, Oriana Mandolfo, Kevin K Kim, George Bou-Gharios, Joe Swift, Brian W Bigger, Karl E Kadler
Collagen fibril formation at the plasma membrane occurs independently from collagen secretion. bioRxiv : the preprint server for biology (2024)
Polly Downton, Fabio Sanna, Robert Maidstone, Toryn M Poolman, Edward A Hayter, Suzanna H Dickson, Nick A Ciccone, James O Early, Antony D Adamson, David G Spiller, Devin Amanda Simpkins, Matthew Baxter, Roman Fischer, Magnus Rattray, Andrew S I Loudon, Julie E Gibbs, David A Bechtold, David W Ray
Chronic inflammatory arthritis drives systemic changes in circadian energy metabolism. Proceedings of the National Academy of Sciences of the United States of America 119 (18) (2022)
Alkisti Manousaki, James Bagnall, David G Spiller, Laura Natalia Balarezo-Cisneros, Michael White, Daniela Delneri
Quantitative Characterisation of Low Abundant Yeast Mitochondrial Proteins Reveals Compensation for Haplo-Insufficiency in Different Environments. International journal of molecular sciences 23 (15) (2022)
Alex A Koch, James S Bagnall, Nicola J Smyllie, Nicola Begley, Antony D Adamson, Jennifer L Fribourgh, David G Spiller, Qing-Jun Meng, Carrie L Partch, Korbinian Strimmer, Thomas A House, Michael H Hastings, Andrew S I Loudon
Quantification of protein abundance and interaction defines a mechanism for operation of the circadian clock. eLife 11 (2022)
Katie A Lloyd, Stamatia Papoutsopoulou, Emily Smith, Philip Stegmaier, Francois Bergey, Lorna Morris, Madeleine Kittner, Hazel England, David G Spiller, Michael R H White, Carrie A Duckworth, Barry J Campbell, Vladimir V Poroikov, Vitor A P Martins Dos Santos, Alexander E Kel, Werner Muller, David Mark Pritchard, Chris S Probert, Michael D Burkitt, null null
Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease. Disease models & mechanisms 13 (11) (2020)